Swiss stocks – Factors to watch on May 21

ZURICH, May 21 (BestGrowthStock) – Swiss stocks were set to ease on
Friday, with European indices also indicated lower, on mounting
concerns that uncertainties over sovereign debt and more
stringent financial regulation could derail economic recovery.

The Swiss blue-chip index SMI(.SSMI: ) was indicated to fall
51 points to 6,210 points, premarket data provided by bank
Clariden Leu showed.(CLPRE: )

The following are some of the main factors expected to
affect Swiss stocks on Friday:

ROCHE (ROG.VX: )

* Continued use of Rituxan cut by about 50 percent the risk
that follicular lymphoma patients would have their cancer
return, according to a late-stage study of the drug, which is
sold by Roche Holding AG (ROG.VX: ) and Biogen Idec Inc.
[ID:nN20220760]

* The European Medicines Agency (EMA) came under fire on
Friday for recent decisions related to drugs from Roche (ROG.VX: )
and AstraZeneca Plc, which some medical experts said were
questionable. [ID:nLDE64J0K9]

For related news, click on [ROG.VX]

LOGITECH (LOGN.VX: )

The Switzerland-listed technology company sees a Web-TV
format launched with three big-hitting partners on Thursday
driving its sales in years to come, Chairman Guerrino De Luca
told Reuters.

For related news click on [LOGN.VX]

ECONOMY [M-CH]

COMPANY STATEMENTS [CNR-CH]

* Baloise (BALN.VX: ) appoints new CEO for its Croatian unit

* Feintool (FTON.S: ) in its half-year result as at 31 March
2010 posted slightly lower sales of just under CHF 180 million
Swiss francs year-on-year and achieved an operating result
(EBIT) of CHF 3.5 million francs.

* Cytos (CYTN.S: ) said a placebo-controlled phase II study
showed CYT003-QbG10 was safe and effective against allergic
asthma.

EQUITY RESEARCH [CH-RCH]

FOR COMPANIES TRADING EX-DIVIDEND, PLEASE CLICK ON:

(.EX.S: ) for all Swiss stocks

(.EXSMI.S: ) for blue chips

(.EXNSMI.S: ) for other stocks

Stock Investing

Swiss stocks – Factors to watch on May 21